Literature DB >> 6514931

Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis.

M Le Moal, R Dantzer, P Mormède, A Baduel, C Lebrun, A Ettenberg, D van der Kooy, J Wenger, S Deyo, G F Koob.   

Abstract

In this review we present data summarizing our studies concerning the mechanism of action for the behavioral effects of peripheral arginine vasopressin (AVP) administration. We have demonstrated a clear performance improvement in a one trial appetitive task designed to measure the memory-learning process. This behavioral effect is blocked by peptide analogs which block the pressor response to AVP. From these data, and from other data obtained in aversively motivated tasks, we hypothesize that peripheral AVP injections induce effects of physiological-endocrinological origin and that these peripheral signals (e.g. vasopressor actions) alert and arouse the animal, thus helping to improve its association of environmental events. This hypothesis is similar to that proposed by others regarding peripheral hormones and memory and still leaves open the possibility that vasopressin in the brain acts independently of the above proposed action for peripherally derived vasopressin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514931     DOI: 10.1016/0306-4530(84)90042-8

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  11 in total

1.  Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.

Authors:  A Sahgal; C Wright; I N Ferrier
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Vasopressin has general rate-decreasing effects on schedules maintaining either high or low response rates.

Authors:  F van Haaren; R P Heinsbroek; A Louwerse; N E van de Poll
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Comparative physiological features of the regulatory effect of vasopressin on higher nervous activity in an ascending series of mammals.

Authors:  T N Sollertinskaya
Journal:  Neurosci Behav Physiol       Date:  1997 Nov-Dec

4.  Modulation of social memory in male rats by neurohypophyseal peptides.

Authors:  R Dantzer; R M Bluthe; G F Koob; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

6.  Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats.

Authors:  Scott Edwards; Miguel Guerrero; Ola M Ghoneim; Edward Roberts; George F Koob
Journal:  Addict Biol       Date:  2011-02-11       Impact factor: 4.280

7.  Vasopressin but not oxytocin enhances cortical arousal: an integrative hypothesis on behavioral effects of neurohypophyseal hormones.

Authors:  G Fehm-Wolfsdorf; G Bachholz; J Born; K Voigt; H L Fehm
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Central actions of arginine vasopressin and a V1a receptor antagonist on maternal aggression, maternal behavior, and grooming in lactating rats.

Authors:  Benjamin C Nephew; Robert S Bridges
Journal:  Pharmacol Biochem Behav       Date:  2008-06-29       Impact factor: 3.533

9.  Specificity of aversive stimulus properties of vasopressin.

Authors:  R M Bluthé; R Dantzer; P Mormède; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat.

Authors:  C L Ehlers; T K Reed; M Wang; C J Lebrun; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.